Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

1.3K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.3K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.9K
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

2.5K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
2.5K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

798
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
798
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

508
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
508
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

391
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interoceptive Awareness and Female Orgasm Frequency and Satisfaction.

Brain sciences·2025
Same author

Multiple drug-delivery strategies to enhance the pharmacological and toxicological properties of Mefenamic acid.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2024
Same author

Evaluation of Reading Level of Result Letters Sent to Patients from an Academic Primary Care Practice.

Health services research and managerial epidemiology·2023
Same author

Protocol for a pilot randomised controlled trial to evaluate integrated support from pharmacist independent prescriber and third sector worker for people experiencing homelessness: the PHOENIx community pharmacy study.

Pilot and feasibility studies·2023
Same author

The effectiveness of trauma-focused psychotherapy for complex post-traumatic stress disorder: A retrospective study.

European psychiatry : the journal of the Association of European Psychiatrists·2022
Same author

Rapid intrapartum test for maternal group B streptococcal colonisation and its effect on antibiotic use in labouring women with risk factors for early-onset neonatal infection (GBS2): cluster randomised trial with nested test accuracy study.

BMC medicine·2022

Related Experiment Video

Updated: Apr 18, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

709

Pediatric hypertension: a growing problem.

Debra Ahern1, Emily Dixon2

  • 1Department of Community and Family Medicine, TMC Lakewood, 7900 Lee's Summit Road, Kansas City, MO 64139, USA.

Primary Care
|January 31, 2015
PubMed
Summary

Pediatric hypertension prevalence is 1-5% in the US, rising with childhood obesity. Key questions for primary care physicians involve identifying at-risk children and determining appropriate screening and treatment strategies.

Keywords:
Pediatric hypertensionPediatric lifestyle changePediatric obesityPediatric screeningPediatric workup

More Related Videos

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.9K
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

14.7K

Related Experiment Videos

Last Updated: Apr 18, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

709
Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.9K
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

14.7K

Area of Science:

  • Pediatric Medicine
  • Cardiovascular Health
  • Public Health

Background:

  • Hypertension in children and adolescents was historically considered rare.
  • Current estimates place the prevalence of pediatric hypertension between 1% and 5% in the United States.
  • The increasing prevalence of primary hypertension is closely linked to the rising rates of obesity in the pediatric population.

Purpose of the Study:

  • To address the growing concern of hypertension in children and adolescents.
  • To highlight key clinical questions regarding risk, screening, and treatment for pediatric hypertension.
  • To emphasize the importance of these issues for physicians in primary care settings.

Main Methods:

  • This abstract does not detail specific methods.
  • It focuses on the clinical implications and unresolved questions in pediatric hypertension management.
  • The content is based on current epidemiological understanding and clinical practice challenges.

Main Results:

  • Pediatric hypertension affects 1-5% of children and adolescents in the US.
  • The prevalence of primary hypertension is increasing, correlating with rising pediatric body mass index.
  • Significant clinical questions remain regarding risk stratification, screening protocols, and therapeutic interventions.

Conclusions:

  • Pediatric hypertension is a significant and growing public health concern.
  • Primary care physicians face critical, often controversial, decisions regarding screening and treatment.
  • Further research and consensus are needed to guide optimal management of hypertension in young people.